Toggle Main Menu Toggle Search


Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin

Lookup NU author(s): Dr David Sheridan, Dr David Price, Dr Matthias Schmid, Professor Geoff Toms, Dr Peter Donaldson, Dr R Neely, Professor Margaret Bassendine


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Sheridan DA, Price DA, Schmid ML, Toms GL, Donaldson P, Neely D, Bassendine MF

Publication type: Article

Journal: Alimentary Pharmacology & Therapeutics

Year: 2009

Volume: 29

Issue: 12

Pages: 1282-1290

ISSN (print): 0269-2813

ISSN (electronic): 1365-2036

Publisher: Wiley-Blackwell Publishing Ltd.


DOI: 10.1111/j.1365-2036.2009.04012.x


Altmetrics provided by Altmetric


    Link to this publication